They also discovered that in the subgroup analysis by cancer type, HHLA2 overexpression correlated with poor OS in patients with clear cell renal cell carcinoma, gastric cancer, cholangiocarcinoma, lung cancer, and other cancer types, but not in patients with ovarian cancer [11]. The gene discussed is HHLA2; the disease is cholangiocarcinoma.